10 Narcolepsy Clinical Trials in Miami, FL (2026)

Q: How do I join a clinical trial in Miami?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you.

Recruiting Narcolepsy Studies in Miami

NCT06767683Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

The purpose of this study is to continue to measure the safety, tolerability, and durability of treatment effect in subjects with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypers...

Miami, FLPHASE2786 participantsAlkermes, Inc.

View Study Details

NCT06752668Recruiting

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepines...

Miami, FLPHASE2248 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT07598708Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Narcolepsy Type 1 (NT1) and Narcolepsy Type 2 (NT2) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with...

Miami, FLPHASE2222 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT07540897Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

The purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared wi...

Miami, FLPHASE3150 participantsAlkermes, Inc.

View Study Details

NCT07455383Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Miami, FLPHASE3150 participantsAlkermes, Inc.

View Study Details

NCT07625280Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

The purpose of this study is to evaluate the efficacy and safety of expanded Xywav dosing regimens in adult participants with narcolepsy or idiopathic hypersomnia (IH)....

Miami, FLPHASE3120 participantsJazz Pharmaceuticals

View Study Details

NCT07633301Recruiting

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Narcolepsy is a sleep disorder that disrupts a person's regular sleep-wake cycle. It causes extreme sleepiness during the day (called excessive daytime sleepiness \[EDS\]), where a person may fall asl...

Miami, FLPHASE292 participantsTakeda

View Study Details

NCT07096674Recruiting

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT...

Miami, FLPHASE290 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT06952699Recruiting

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Narcolepsy without cataplexy or Narcolepsy Type 2 (NT2) is a lifelong condition that makes people very sleepy during the day, regardless of how much sleep they get at night. People with NT2 may fall a...

Miami, FLPHASE288 participantsTakeda

View Study Details

NCT07493265Recruiting

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive daytime sleepiness (EDS) as assessed by Mean ...

Miami, FLPHASE264 participantsEisai Inc.

View Study Details

About Narcolepsy Clinical Trials in Miami

Narcolepsy is a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles, causing excessive daytime sleepiness and sudden loss of muscle tone (cataplexy). It is caused by a deficiency of the brain chemical hypocretin. Treatment includes stimulant medications and sodium oxybate.

There are currently 10 narcolepsy clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 2,010 participants. Research is being sponsored by Alkermes, Inc., Centessa Pharmaceuticals (UK) Limited, Jazz Pharmaceuticals and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Narcolepsy Clinical Trials in Miami — FAQ

Are there narcolepsy clinical trials in Miami?

Yes, there are 10 narcolepsy clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What narcolepsy treatments are being tested?

The 10 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy.

Data updated October 12, 2026 from ClinicalTrials.gov